H. Samonigg
- Oncology top 1%
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 8
- Colorectal Cancer Treatments and Studies 8
- Cancer Research top 2%
- Breast Cancer Treatment Studies 17
- Hematology top 5%
- Genetics top 5%
- Estrogen and related hormone effects 9
-
- Advanced Breast Cancer Therapies 7
-
- Genetic factors in colorectal cancer 7
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Armin GergerMichael StotzJoanna SzkanderaTatjana StojakovićGudrun AbsengerMartin PichlerMichael GnantR. Jakesz
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Journal of Clinical Oncology (14 papers)British Journal of Cancer (12 papers)European Journal of Cancer (8 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
H. Samonigg
70 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 111
- Oncology 1.8k
- Cancer Research 905
- Hematology 238
- Genetics 463
- Pulmonary and Respiratory Medicine 482
Countries citing papers authored by H. Samonigg
This map shows the geographic impact of H. Samonigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Samonigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Samonigg more than expected).
Fields of papers citing papers by H. Samonigg
This network shows the impact of papers produced by H. Samonigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Samonigg. The network helps show where H. Samonigg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Samonigg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 12 | |
| 2 | 2013 | 17 | |
| 3 | 2013 | 162 | |
| 4 | 2013 | 16 | |
| 5 | 2012 | 38 | |
| 6 | 2011 | 14 | |
| 7 | 2008 | 59 | |
| 8 | 2007 | 22 | |
| 9 | 2007 | 82 | |
| 10 | 2006 | 33 | |
| 11 | 2003 | 1 | |
| 12 | 2003 | 57 | |
| 13 | 2003 | 3 | |
| 14 | 2002 | 11 | |
| 15 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 159 |
| 16 | 1999 | 4 | |
| 17 | 1999 | 28 | |
| 18 | 1998 | 12 | |
| 19 | 1995 | 1 | |
| 20 | 1995 | 9 |
About H. Samonigg
H. Samonigg is a scholar working on Oncology, Cancer Research, Dermatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Cancer Treatment and Pharmacology (13 papers), Estrogen and related hormone effects (9 papers), HER2/EGFR in Cancer Research (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Advanced Breast Cancer Therapies (7 papers), Genetic factors in colorectal cancer (7 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (905 citations), Hematology (238 citations), Genetics (463 citations) and Pulmonary and Respiratory Medicine (482 citations). H. Samonigg has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Armin Gerger, Michael Stotz, Joanna Szkandera, Tatjana Stojaković, Gudrun Absenger, Martin Pichler, Michael Gnant, R. Jakesz, Renate Schaberl-Moser and E. Kubista. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Cancer Research and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.